Healthcare provider profile · identity verified

Douglas G Dorman, MD

Family Practice · YORKVILLE, IL · NPI 1891711958

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1024	305
Amlodipine Besylate	Amlodipine Besylate	500	140
Losartan Potassium	Losartan Potassium	475	143
Lisinopril	Lisinopril	467	129
Levothyroxine Sodium	Levothyroxine Sodium	423	107
Metoprolol Succinate	Metoprolol Succinate	331	95
Pantoprazole Sodium	Pantoprazole Sodium	283	84
Omeprazole	Omeprazole	276	88
Metformin Hcl	Metformin Hcl	275	84
Simvastatin	Simvastatin	262	65
Metformin Hcl Er	Metformin Hcl	252	79
Hydrochlorothiazide	Hydrochlorothiazide	249	78
Tamsulosin Hcl	Tamsulosin Hcl	225	70
Gabapentin	Gabapentin	208	68
Metoprolol Tartrate	Metoprolol Tartrate	184	50
Pravastatin Sodium	Pravastatin Sodium	167	44
Furosemide	Furosemide	156	51
Carvedilol	Carvedilol	153	41
Escitalopram Oxalate	Escitalopram Oxalate	151	52
Glipizide Er	Glipizide	148	45
Rosuvastatin Calcium	Rosuvastatin Calcium	140	45
Sertraline Hcl	Sertraline Hcl	140	41
Allopurinol	Allopurinol	135	39
Lovastatin	Lovastatin	131	38
Ozempic	Semaglutide	125	24
Trazodone Hcl	Trazodone Hcl	107	35
Clopidogrel	Clopidogrel Bisulfate	104	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	102	30
Fluoxetine Hcl	Fluoxetine Hcl	93	22
Potassium Chloride	Potassium Chloride	93	32
Donepezil Hcl	Donepezil Hcl	92	21
Doxazosin Mesylate	Doxazosin Mesylate	91	26
Glipizide	Glipizide	89	30
Jardiance	Empagliflozin	89	26
Albuterol Sulfate Hfa	Albuterol Sulfate	86	31
Alprazolam	Alprazolam	81	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	80	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	26
Alendronate Sodium	Alendronate Sodium	76	25
Atenolol	Atenolol	75	22
Finasteride	Finasteride	73	22
Warfarin Sodium	Warfarin Sodium	70	19
Eliquis	Apixaban	67	18
Enalapril Maleate	Enalapril Maleate	65	18
Ezetimibe	Ezetimibe	63	20
Meloxicam	Meloxicam	63	15
Montelukast Sodium	Montelukast Sodium	60	16
Fluticasone Propionate	Fluticasone Propionate	57	19
Fenofibrate	Fenofibrate	53	15
Valsartan	Valsartan	53	16
Mirtazapine	Mirtazapine	52	13
Paroxetine Hcl	Paroxetine Hcl	51	13
Synthroid	Levothyroxine Sodium	50	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	45	21
Lorazepam	Lorazepam	44	13
Duloxetine Hcl	Duloxetine Hcl	43	13
Famotidine	Famotidine	43	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	11
Ventolin Hfa	Albuterol Sulfate	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	15
Bumetanide	Bumetanide	38	11
Glimepiride	Glimepiride	38	13
Nifedipine Er	Nifedipine	38	11
Ibandronate Sodium	Ibandronate Sodium	37	14
Venlafaxine Hcl Er	Venlafaxine Hcl	37	12
Tramadol Hcl	Tramadol Hcl	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	21
Xarelto	Rivaroxaban	35	11
Hydralazine Hcl	Hydralazine Hcl	34	11
Pregabalin	Pregabalin	34	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Januvia	Sitagliptin Phosphate	27	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Myrbetriq	Mirabegron	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Trulicity	Dulaglutide	22	suppressed
Ramipril	Ramipril	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Victoza 3-Pak	Liraglutide	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Baclofen	Baclofen	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Lamotrigine Er	Lamotrigine	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Nystatin	Nystatin	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Torsemide	Torsemide	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error